pillbase.ru

Lytgobi

Active substance: futibatinib

Futibatinib

Centralised EU authorisationActive

Marketing holder: Taiho Pharma Netherlands B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • LYTGOBI
    TABLET · FUTIBATINIB 16 mg/1
    64842-0127
    TAIHO PHARMACEUTICAL CO., LTD.
  • LYTGOBI
    TABLET · FUTIBATINIB 4 mg/1
    64842-0120
    TAIHO PHARMACEUTICAL CO., LTD.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12092-4975-7444-9ad6-6263d75a3e25,01a1209d-de3e-7eea-a170-db09011ef249;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005627
Registration status
Active
ATC code
L01EN04
Sources
  • product · EMA · EMEA/H/C/005627 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005627 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005627 · Verified 2026-10-09